Eli Lilly and Company (LLY)
USD 855.2
(16.37%)
USD 855.2
(16.37%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 16.71 Billion USD | 26.35% |
| 2022 | 13.63 Billion USD | 1.29% |
| 2021 | 13.45 Billion USD | 10.25% |
| 2020 | 12.2 Billion USD | 3.37% |
| 2019 | 11.8 Billion USD | 7.1% |
| 2018 | 11.02 Billion USD | -7.11% |
| 2017 | 11.86 Billion USD | 1.49% |
| 2016 | 11.69 Billion USD | 3.23% |
| 2015 | 11.32 Billion USD | -0.22% |
| 2014 | 11.35 Billion USD | -10.29% |
| 2013 | 12.65 Billion USD | -1.05% |
| 2012 | 12.79 Billion USD | -0.85% |
| 2011 | 12.9 Billion USD | 8.07% |
| 2010 | 11.93 Billion USD | 6.41% |
| 2009 | 11.21 Billion USD | 7.18% |
| 2008 | 10.46 Billion USD | 9.24% |
| 2007 | 9.58 Billion USD | 19.49% |
| 2006 | 8.01 Billion USD | 6.6% |
| 2005 | 7.52 Billion USD | 7.84% |
| 2004 | 6.97 Billion USD | 8.89% |
| 2003 | 6.4 Billion USD | 14.93% |
| 2002 | 5.57 Billion USD | -1.4% |
| 2001 | 5.65 Billion USD | 7.73% |
| 2000 | 5.24 Billion USD | 5.34% |
| 1999 | 4.98 Billion USD | 1.91% |
| 1998 | 4.88 Billion USD | 16.2% |
| 1997 | 4.2 Billion USD | 12.92% |
| 1996 | 3.72 Billion USD | 7.97% |
| 1995 | 3.45 Billion USD | 29.25% |
| 1994 | 2.66 Billion USD | -37.03% |
| 1993 | 4.23 Billion USD | 21.71% |
| 1992 | 3.48 Billion USD | 33.82% |
| 1991 | 2.6 Billion USD | 9.52% |
| 1990 | 2.37 Billion USD | 19.76% |
| 1989 | 1.98 Billion USD | 4.98% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 4.83 Billion USD | 0.11% |
| 2024 Q2 | 4.82 Billion USD | 4.65% |
| 2024 Q1 | 4.61 Billion USD | -0.05% |
| 2023 Q1 | 3.73 Billion USD | 2.62% |
| 2023 Q2 | 4.28 Billion USD | 14.66% |
| 2023 FY | 17.22 Billion USD | 26.35% |
| 2023 Q3 | 4.21 Billion USD | -1.61% |
| 2023 Q4 | 4.61 Billion USD | 9.57% |
| 2022 FY | 13.63 Billion USD | 1.29% |
| 2022 Q3 | 3.41 Billion USD | 0.3% |
| 2022 Q4 | 3.63 Billion USD | 6.5% |
| 2022 Q1 | 3.16 Billion USD | -10.8% |
| 2022 Q2 | 3.4 Billion USD | 7.54% |
| 2021 Q2 | 3.35 Billion USD | 3.0% |
| 2021 Q3 | 3.28 Billion USD | -2.13% |
| 2021 Q4 | 3.55 Billion USD | 8.05% |
| 2021 FY | 13.45 Billion USD | 10.25% |
| 2021 Q1 | 3.26 Billion USD | -3.87% |
| 2020 Q4 | 3.39 Billion USD | 11.78% |
| 2020 Q1 | 2.94 Billion USD | -10.3% |
| 2020 Q2 | 2.83 Billion USD | -3.5% |
| 2020 FY | 12.2 Billion USD | 3.37% |
| 2020 Q3 | 3.03 Billion USD | 6.89% |
| 2019 Q4 | 3.27 Billion USD | 17.41% |
| 2019 Q1 | 2.74 Billion USD | -17.12% |
| 2019 Q2 | 2.98 Billion USD | 8.77% |
| 2019 FY | 11.8 Billion USD | 7.1% |
| 2019 Q3 | 2.79 Billion USD | -6.54% |
| 2018 FY | 11.02 Billion USD | -7.11% |
| 2018 Q2 | 2.98 Billion USD | 11.58% |
| 2018 Q3 | 2.95 Billion USD | -0.9% |
| 2018 Q1 | 2.67 Billion USD | -17.73% |
| 2018 Q4 | 3.31 Billion USD | 12.01% |
| 2017 Q2 | 2.95 Billion USD | 6.3% |
| 2017 Q4 | 3.25 Billion USD | 13.18% |
| 2017 FY | 11.86 Billion USD | 1.49% |
| 2017 Q1 | 2.78 Billion USD | -14.12% |
| 2017 Q3 | 2.87 Billion USD | -2.82% |
| 2016 Q4 | 3.24 Billion USD | 15.66% |
| 2016 Q2 | 2.95 Billion USD | 9.78% |
| 2016 Q3 | 2.8 Billion USD | -5.3% |
| 2016 FY | 11.69 Billion USD | 3.23% |
| 2016 Q1 | 2.69 Billion USD | -16.89% |
| 2015 Q4 | 3.24 Billion USD | 19.25% |
| 2015 FY | 11.32 Billion USD | -0.22% |
| 2015 Q1 | 2.56 Billion USD | -14.16% |
| 2015 Q2 | 2.8 Billion USD | 9.45% |
| 2015 Q3 | 2.71 Billion USD | -3.06% |
| 2014 Q2 | 2.85 Billion USD | 10.22% |
| 2014 FY | 11.35 Billion USD | -10.29% |
| 2014 Q1 | 2.59 Billion USD | -24.35% |
| 2014 Q3 | 2.91 Billion USD | 1.96% |
| 2014 Q4 | 2.98 Billion USD | 2.41% |
| 2013 Q3 | 3.02 Billion USD | -5.26% |
| 2013 Q4 | 3.42 Billion USD | 13.18% |
| 2013 FY | 12.65 Billion USD | -1.05% |
| 2013 Q1 | 3 Billion USD | -12.8% |
| 2013 Q2 | 3.19 Billion USD | 6.6% |
| 2012 Q2 | 3.25 Billion USD | 8.43% |
| 2012 Q4 | 3.44 Billion USD | 10.98% |
| 2012 Q3 | 3.1 Billion USD | -4.66% |
| 2012 Q1 | 2.99 Billion USD | -14.04% |
| 2012 FY | 12.79 Billion USD | -0.85% |
| 2011 Q1 | 2.9 Billion USD | -15.09% |
| 2011 Q3 | 3.19 Billion USD | -3.18% |
| 2011 Q4 | 3.48 Billion USD | 9.07% |
| 2011 Q2 | 3.3 Billion USD | 13.54% |
| 2011 FY | 12.9 Billion USD | 8.07% |
| 2010 FY | 11.93 Billion USD | 6.41% |
| 2010 Q3 | 2.91 Billion USD | -0.95% |
| 2010 Q4 | 3.42 Billion USD | 17.57% |
| 2010 Q1 | 2.65 Billion USD | -16.29% |
| 2010 Q2 | 2.94 Billion USD | 10.9% |
| 2009 Q4 | 3.17 Billion USD | 12.26% |
| 2009 Q2 | 2.85 Billion USD | 15.23% |
| 2009 Q3 | 2.82 Billion USD | -1.04% |
| 2009 Q1 | 2.47 Billion USD | -11.11% |
| 2009 FY | 11.21 Billion USD | 7.18% |
| 2008 Q1 | 2.42 Billion USD | -10.4% |
| 2008 Q3 | 2.6 Billion USD | -1.86% |
| 2008 Q2 | 2.65 Billion USD | 9.23% |
| 2008 Q4 | 2.78 Billion USD | 7.06% |
| 2008 FY | 10.46 Billion USD | 9.24% |
| 2007 Q4 | 2.7 Billion USD | 16.67% |
| 2007 FY | 9.58 Billion USD | 19.49% |
| 2007 Q1 | 2.17 Billion USD | 0.1% |
| 2007 Q2 | 2.37 Billion USD | 9.59% |
| 2007 Q3 | 2.32 Billion USD | -2.39% |
| 2006 FY | 8.01 Billion USD | 6.6% |
| 2006 Q4 | 2.16 Billion USD | 11.0% |
| 2006 Q3 | 1.95 Billion USD | -2.92% |
| 2006 Q2 | 2.01 Billion USD | 6.85% |
| 2006 Q1 | 1.88 Billion USD | -5.79% |
| 2005 Q2 | 1.9 Billion USD | 6.47% |
| 2005 Q3 | 1.82 Billion USD | -4.54% |
| 2005 Q4 | 1.99 Billion USD | 9.75% |
| 2005 FY | 7.52 Billion USD | 7.84% |
| 2005 Q1 | 1.79 Billion USD | -0.62% |
| 2004 Q1 | 1.71 Billion USD | -7.25% |
| 2004 Q3 | 1.6 Billion USD | -13.36% |
| 2004 Q4 | 1.8 Billion USD | 12.26% |
| 2004 FY | 6.97 Billion USD | 8.89% |
| 2004 Q2 | 1.85 Billion USD | 8.41% |
| 2003 Q2 | 1.58 Billion USD | 9.81% |
| 2003 Q1 | 1.44 Billion USD | -3.41% |
| 2003 Q3 | 1.53 Billion USD | -3.42% |
| 2003 Q4 | 1.84 Billion USD | 20.42% |
| 2003 FY | 6.4 Billion USD | 14.93% |
| 2002 Q1 | 1.28 Billion USD | -13.07% |
| 2002 Q4 | 1.49 Billion USD | 11.79% |
| 2002 Q3 | 1.33 Billion USD | -8.44% |
| 2002 FY | 5.57 Billion USD | -1.4% |
| 2002 Q2 | 1.46 Billion USD | 14.11% |
| 2001 Q1 | 1.28 Billion USD | 13.71% |
| 2001 Q4 | 1.47 Billion USD | 2.84% |
| 2001 FY | 5.65 Billion USD | 7.73% |
| 2001 Q3 | 1.43 Billion USD | -2.17% |
| 2001 Q2 | 1.46 Billion USD | 13.95% |
| 2000 Q3 | 1.42 Billion USD | 0.25% |
| 2000 Q1 | 1.26 Billion USD | -8.82% |
| 2000 FY | 5.24 Billion USD | 5.34% |
| 2000 Q2 | 1.42 Billion USD | 12.86% |
| 2000 Q4 | 1.12 Billion USD | -20.95% |
| 1999 Q1 | 1.11 Billion USD | -20.3% |
| 1999 Q3 | 1.25 Billion USD | 2.72% |
| 1999 Q4 | 1.38 Billion USD | 10.34% |
| 1999 FY | 4.98 Billion USD | 1.91% |
| 1999 Q2 | 1.22 Billion USD | 9.27% |
| 1998 Q4 | 1.4 Billion USD | 12.75% |
| 1998 Q3 | 1.24 Billion USD | 4.58% |
| 1998 Q2 | 1.19 Billion USD | 13.34% |
| 1998 Q1 | 1.04 Billion USD | -12.62% |
| 1998 FY | 4.88 Billion USD | 16.2% |
| 1997 Q4 | 1.2 Billion USD | 13.63% |
| 1997 Q1 | 911.9 Million USD | -14.61% |
| 1997 Q2 | 1.03 Billion USD | 13.54% |
| 1997 Q3 | 1.05 Billion USD | 2.12% |
| 1997 FY | 4.2 Billion USD | 12.92% |
| 1996 Q3 | 899.7 Million USD | 1.25% |
| 1996 Q4 | 1.06 Billion USD | 18.7% |
| 1996 FY | 3.72 Billion USD | 7.97% |
| 1996 Q1 | 868.7 Million USD | -11.79% |
| 1996 Q2 | 888.6 Million USD | 2.29% |
| 1995 Q4 | 984.8 Million USD | 16.52% |
| 1995 FY | 3.45 Billion USD | 29.25% |
| 1995 Q3 | 845.2 Million USD | 1.1% |
| 1995 Q2 | 836 Million USD | 6.63% |
| 1995 Q1 | 784 Million USD | 16.46% |
| 1994 Q4 | 673.2 Million USD | -5.95% |
| 1994 Q1 | 601.3 Million USD | -74.4% |
| 1994 FY | 2.66 Billion USD | -37.03% |
| 1994 Q2 | 678.9 Million USD | 12.91% |
| 1994 Q3 | 715.8 Million USD | 5.44% |
| 1993 Q3 | 650.1 Million USD | 2.41% |
| 1993 Q2 | 634.8 Million USD | 4.91% |
| 1993 Q1 | 605.1 Million USD | -44.71% |
| 1993 FY | 4.23 Billion USD | 21.71% |
| 1993 Q4 | 2.34 Billion USD | 261.34% |
| 1992 Q1 | 541.9 Million USD | -43.24% |
| 1992 Q3 | 1.25 Billion USD | 110.25% |
| 1992 Q2 | 595.2 Million USD | 9.84% |
| 1992 FY | 3.48 Billion USD | 33.82% |
| 1992 Q4 | 1.09 Billion USD | -12.55% |
| 1991 FY | 2.6 Billion USD | 9.52% |
| 1991 Q3 | 540 Million USD | -3.19% |
| 1991 Q2 | 557.8 Million USD | 1.38% |
| 1991 Q4 | 954.7 Million USD | 76.8% |
| 1991 Q1 | 550.2 Million USD | -36.87% |
| 1990 FY | 2.37 Billion USD | 19.76% |
| 1990 Q2 | 501.1 Million USD | 7.37% |
| 1990 Q4 | 871.6 Million USD | 62.31% |
| 1990 Q1 | 466.7 Million USD | -26.3% |
| 1990 Q3 | 537 Million USD | 7.16% |
| 1989 FY | 1.98 Billion USD | 4.98% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q3 | 455.2 Million USD | -0.87% |
| 1989 Q2 | 459.2 Million USD | 0.0% |
| 1989 Q4 | 633.2 Million USD | 39.1% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbbVie Inc. | 24.83 Billion USD | 32.69% |
| Bristol-Myers Squibb Company | 34.31 Billion USD | 51.282% |
| Bristol-Myers Squibb Company Ce | 34.31 Billion USD | 51.282% |
| Johnson & Johnson | 58.6 Billion USD | 71.476% |
| Merck & Co., Inc. | 43.98 Billion USD | 61.998% |
| Novartis AG | 24.87 Billion USD | 32.787% |
| Organon & Co. | 2.41 Billion USD | -591.05% |
| Pfizer Inc. | 25.45 Billion USD | 34.316% |